Polygiene AB (publ.) Stock Nasdaq Stockholm
Equities
SE0007692157
Specialty Chemicals
Sales 2024 * | 128M 11.81M | Sales 2025 * | 144M 13.22M | Capitalization | 333M 30.66M |
---|---|---|---|---|---|
Net income 2024 * | -4M -368K | Net income 2025 * | 6M 552K | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | 34M 3.13M | Net cash position 2025 * | 38M 3.5M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-82.9
x | P/E ratio 2025 * |
50.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.11% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrika Bjork
CEO | Chief Executive Officer | 56 | 17-05-09 |
Niklas Blomstedt
DFI | Director of Finance/CFO | - | 22-09-14 |
Sue Bethel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 18-12-31 | |
Director/Board Member | 71 | 23-05-10 | |
Daniel Röme
CTO | Chief Tech/Sci/R&D Officer | 48 | 17-12-31 |
1st Jan change | Capi. | |
---|---|---|
+10.81% | 62.84B | |
+12.89% | 39.67B | |
+17.83% | 25.73B | |
+5.36% | 18.27B | |
-0.95% | 17.17B | |
-21.87% | 15.81B | |
+0.61% | 14.96B | |
-20.42% | 13.51B | |
+35.12% | 12.66B |